Related Experiment Video
Updated: Jun 16, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Daurisoline suppressed early afterdepolarizations and inhibited L-type calcium current
Qiang-Ni Liu1, Li Zhang, Pei-Li Gong
1Department of Pharmacology, Huazhong University of Science and Technology, Wuhan, China.
Daurisoline (DS) effectively inhibits early afterdepolarizations (EADs) in hypertrophied heart cells by blocking L-type calcium currents. This finding suggests DS has potential as an antiarrhythmic agent.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Daurisoline (DS) has demonstrated antiarrhythmic effects in prior studies.
- Early afterdepolarizations (EADs) are a significant concern in cardiac hypertrophy.
- Investigating DS's impact on EADs and their underlying mechanisms is crucial.
Purpose of the Study:
- To investigate the effects of Daurisoline (DS) on early afterdepolarizations (EADs) in a rabbit model of cardiac hypertrophy.
- To elucidate the potential mechanisms by which DS influences EADs, particularly its effect on L-type calcium currents (I(Ca-L)).
Main Methods:
- Cardiac hypertrophy was induced in rabbits via abdominal aorta coarctation.
- Standard microelectrode technique was used to study action potential duration (APD) and EAD incidence in hypertrophied papillary muscles.
- Whole-cell patch clamp recorded L-type calcium current (I(Ca-L)) in isolated ventricular cells.
Main Results:
- In hypertrophied papillary muscles, dofetilide (dof) induced EADs (66.7%) and prolonged APD.
- Daurisoline (DS) (15 microM) completely inhibited EADs (0%) and shortened the prolonged APD.
- DS inhibited dofetilide-, low [K+], and low [Mg2+] induced EADs in single myocytes, decreasing triangulation and affecting I(Ca-L) parameters.
Conclusions:
- Daurisoline (DS) effectively inhibits early afterdepolarizations (EADs) in cardiac hypertrophy.
- DS's antiarrhythmic effect is likely mediated through the blockade of L-type calcium currents (I(Ca-L)).
- DS shows promise as a therapeutic agent for arrhythmias associated with cardiac hypertrophy.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Depolarizing Blockers: Pharmocokinetics

